Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee. 2: Economic evaluation alongside a randomized controlled trial

Osteoarthritis and Cartilage

Volumn 21, Issue 10, 2013, Pages 1504-1513

  Pinto, D ^a   Robertson, M C ^b   Abbott, J H ^b   Hansen, P ^c   Campbell, A J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cost benefit analysis; Economic evaluation alongside clinical trials; Exercise therapy; Manual therapies; Osteoarthritis, hip; Osteoarthritis, knee; Randomized controlled trial

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; FEMALE; GROSS NATIONAL PRODUCT; HIP OSTEOARTHRITIS; HUMAN; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SHORT FORM 12;

COST-BENEFIT ANALYSIS; ECONOMIC EVALUATION ALONGSIDE CLINICAL TRIALS; EXERCISE THERAPY; MANUAL THERAPIES; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL MANIPULATIONS; NEW ZEALAND; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84884157792     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.06.014     Document Type: Article

References (47)

1. Bijlsma J.W.J., Knahr K. Strategies for the prevention and management of osteoarthritis of the hip and knee. Best Pract Res Clin Rheumatol 2007, 21(1):59-76.
2. Dawson J., Linsell L., Zondervan K., Rose P., Randall T., Carr A., et al. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology 2004, 43(4):497-504.
3. Tobias M. The Burden of Disease and Injury in New Zealand 2001, Ministry of Health, Wellington.
4. Access Economics The Economic Cost of Arthitis in New Zealand 2005, Report for Arthritis New Zealand, Canberra.
5. Murphy L., Helmick C.G. The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs 2012, 112:S13-S19.
6. Osteoarthritis N.I.C.E. The Care and Management of Osteoarthritis in Adults 2008, National Institute for Health and Clinical Excellence, London.
7. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16(2):137-162.
8. Pinto D., Robertson M.C., Hansen P., Abbott J.H. Cost-effectiveness of non-pharmacologic, non-surgical interventions for hip and/or knee osteoarthritis: systematic review. Value Health 2012, 15(1):1-12.
9. Roddy E., Zhang W., Doherty M., Arden N.K., Barlow J., Birrell F., et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee - the MOVE consensus. Rheumatology (Oxford) 2005, 44(1):67-73.
10. Hoeksma H.L., Dekker J., Ronday H.K., Breedveld F.C., Van den Ende C.H. Manual therapy in osteoarthritis of the hip: outcome in subgroups of patients. Rheumatology (Oxford) 2005, 44(4):461-464.
11. Hoeksma H.L., Dekker J., Ronday H.K., Heering A., van der Lubbe N., Vel C., et al. Comparison of manual therapy and exercise therapy in osteoarthritis of the hip: a randomized clinical trial. Arthritis Rheum 2004, 51(5):722-729.
12. Deyle G.D., Allison S.C., Matekel R.L., Ryder M.G., Stang J.M., Gohdes D.D., et al. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther 2005, 85(12):1301-1317.
13. Deyle G.D., Henderson N.E., Matekel R.L., Ryder M.G., Garber M.B., Allison S.C. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med 2000, 132(3):173-181.
14. Abbott J.H., Robertson M.C., Chapple C., Pinto D., Wright A.A., Leon de la Barra S., et al. Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee: a randomized controlled trial. 1: clinical effectiveness. Osteoarthritis Cartilage 2013, 21:525-534.
15. Abbott J.H., Robertson M.C., McKenzie J.E., Baxter G.D., Theis J.C., Campbell A.J., et al. Exercise therapy, manual therapy, or both, for osteoarthritis of the hip or knee: a factorial randomised controlled trial protocol. Trials 2009, 10(1):11.
16. Pinto D., Robertson M.C., Hansen P., Abbott J.H. Economic evaluation within a factorial-design randomised controlled trial of exercise, manual therapy, or both interventions for osteoarthritis of the hip or knee: study protocol. BMJ Open 2011, 1(1). e000136.
17. Altman D.G., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29(8):1039-1049.
18. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthitis Rheum 1991, 34(5):505-514.
19. Ware J., Kosinski M., Keller S.D. A12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34(3):220-233.
20. Brazier J., Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42(9):851-859.
21. Drummond M., Maetzel A., Gabriel S., March L. Towards a reference case for use in future economic evaluations of interventions in osteoarthritis. JRheumatol 2003, 68:26-30.
22. Pinto D., Robertson M.C., Hansen P., Abbott J.H. Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis. BMC Med Res Methodol 2011, 11(1):45.
23. Welte R., Feenstra T., Jager H., Leidl R. Adecision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics 2004, 22(13):857-876.
24. New Zealand National Joint Register. New Zealand National Joint Replacement Register: Canterbury District Health Board.
25. Bhandari A., Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev 2006, 63(2):217-235.
26. van den Hout W.B. The value of productivity: human-capital versus friction-cost method. Ann Rheum Dis 2010, 69:i89-i91.
27. Statistics NZ New Zealand Time Use Survey 2000, Statistics New Zealand, Wellington.
28. Drummond M.F., Jefferson T.O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996, 313(7052):275-283.
29. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the Economics Evaluation of Health Care Programmes 2005, Oxford University Press, New York. 3rd edn.
30. Rubin D.B., Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991, 10(4):585-598.
31. Oostenbrink J.B., Al M.J. The analysis of incomplete cost data due to dropout. Health Econ 2005, 14(8):763-776.
32. Raghunathan T.E., Lepkowski J.M., Van Hoewyk J., Solenberger P. Amultivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001, 27(1):85-95.
33. Glick H.A., Doshi J.A., Sonnad S.S., Polsky D. Economic Evaluation in Clinical Trials 2007, Oxford University Press, Oxford.
34. Polsky D., Glick H. Costing and cost analysis in randomized controlled trials: caveat emptor. Pharmacoeconomics 2009, 27(3):179-188.
35. WHO Threshold Values for Intervention Cost-effectiveness by Region. CHOosing Interventions that are Cost Effective (WHO-CHOICE) 2010, WHO.
36. Cochrane T., Davey R.C., Matthes Edwards S.M. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technol Assess 2005, 9(31). iii-iv, ix-xi, 1-114.
37. Richardson G., Hawkins N., McCarthy C.J., Mills P.M., Pullen R., Roberts C., et al. Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. Int J Technol Assess Health Care 2006, 22(1):84-89.
38. Cottrell E., Roddy E., Foster N.E. The attitudes, beliefs and behaviours of GPs regarding exercise for chronic knee pain: a systematic review. BMC Fam Pract 2010, 11:4.
39. Linsell L., Dawson J., Zondervan K., Randall T., Rose P., Carr A., et al. Prospective study of elderly people comparing treatments following first primary care consultation for a symptomatic hip or knee. Fam Pract 2005, 22(1):118-125.
40. Poitras S., Rossignol M., Avouac J., Avouac B., Cedraschi C., Nordin M., et al. Management recommendations for knee osteoarthritis: how usable are they?. Joint Bone Spine 2010, 77(5):458-465.
41. Croft P. The epidemiology of osteoarthritis: Manchester and beyond. Rheumatology (Oxford) 2005, 44(Suppl.4):iv27-iv32.
42. Marra C.A., Cibere J., Tsuyuki R.T., Soon J.A., Esdaile J.M., Gastonguay L., et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum 2007, 57(7):1238-1244.
43. Wright A.A., Cook C.E., Flynn T.W., Baxter G.D., Abbott J.H. Predictors of response to physical therapy intervention in patients with primary hip osteoarthritis. Phys Ther 2011, 91:510-524.
44. Ramsey S., Willke R., Briggs A., Brown R., Buxton M., Chawla A., et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005, 8(5):521-533.
45. Petrou S., Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011, 342. d1548.
46. Chang R.W., Pellissier J.M., Hazen G.B. Acost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996, 275(11):858-865.
47. Losina E., Walensky R.P., Kessler C.L., Emrani P.S., Reichmann W.M., Wright E.A., et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 2009, 169(12):1113-1122.